Quinacrine

CHEMBL7568 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
400.0 g/mol
LogP
6.0
Phase
4

Quinacrine is an acridine compound with antimalarial, antiprotozoal, and antineoplastic properties that intercalates into DNA, inhibits phospholipase A2, and blocks sodium and calcium channels, producing multiple cellular effects including inhibition of telomerase and induction of apoptosis in cancer cells. It was widely used for malaria prophylaxis during World War II and has been investigated for its anticancer activity in non-small cell lung cancer and other malignancies.

분자량

400.0000 g/mol

LogP

6.00

TPSA

37.40 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12

InChI

InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)

Molecular Formula

C23H30ClN3O

HBD / HBA

1 / 4

회전 가능 결합

9

무거운 원자

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Quinacrine is an acridine compound with antimalarial, antiprotozoal, and antineoplastic properties that intercalates into DNA, inhibits phospholipase A2, and blocks sodium and calcium channels, producing multiple cellular effects including inhibition of telomerase and induction of apoptosis in cancer cells. It was widely used for malaria prophylaxis during World War II and has been investigated for its anticancer activity in non-small cell lung cancer and other malignancies.

Yes, Quinacrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL7568. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 237. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.